FACS analysis and sphere formation assay also showed that the percentage of CD44+/CD24− cells number and the number of spheres were increased with these microRNA inhibitors treatment using U87MG and the patient-derived X01 GBM cells, respectively (Figure 4H,I and Supplementary Figure S2A,B). The gene discussed is CD44; the disease is glioblastoma.